Skip to main content
Caplight Logo









Valius Sciences

Valius Sciences

Private
San Francisco, CaliforniaAI, Data & Cloud Infrastructurehttps://www.valiussciences.com/

Last Round

Seed

Apr 13, 2026

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Valius Sciences is a biotechnology company that provides multi-omic testing and a bioinformatics platform to generate comprehensive molecular profiles for personalized cancer treatment planning.

Sector

AI, Data & Cloud Infrastructure

Verticals

Business Intelligence, Data Integration, Data Governance

Business Model

B2C

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

molecular tumor profilingprecision oncologypersonalized medicineAI oncologymulti-omic dataclinical decision supportcancer diagnosticsfoundation modelsAI-queryable platformgenomic analysistherapeutic target identificationbiotech AIcomputational biologyclinical intelligencepatient-centric diagnostics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Valius Sciences Comparables

Compare Valius Sciences with similar companies based on industry and business-model similarity.

Valius Sciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Roche Holding
76%
Caris Life Sciences
73%
Tempus
72%

Valius Sciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedApr 13, 2026

Key People

Founding team and executive leadership

Sarah Hesse

Co-Founder and Chief Scientific Officer

Founding Team

Edward Larkin

Co-Founder and CEO

Founding Team

Valius Sciences Investors

Notable investors and investment history

Valius Sciences investors
InvestorRounds
Define VenturesSeed
Even One VenturesSeed
Define VenturesSeed
8VCSeed
Basis Set VenturesSeed
The Compound Capital FundSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 13, 2026

    $10M round completed.

  • Apr 1, 2026

    Worked with over 60 patients in first nine months.

Valius Sciences Filings

Explore SEC and related filing metadata, where available.

Valius Sciences filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Valius Sciences's valuation, stock price, and market status.

Is Valius Sciences a public or private company?

Valius Sciences is a private company.

What is the current stock price of Valius Sciences?

Valius Sciences is a private company with no public stock price. No recent secondary market data is available.

How much is Valius Sciences worth (valuation)?

Valuation information for Valius Sciences is not publicly available.

Can I buy Valius Sciences stock?

Valius Sciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Valius Sciences's last funding round?

Valius Sciences's most recent funding round was Seed on April 13, 2026.

Who are the main investors in Valius Sciences?

Key investors in Valius Sciences include 8VC, Basis Set Ventures.

Will Valius Sciences IPO soon?

No public IPO plans have been announced for Valius Sciences.

How can I track Valius Sciences secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Valius Sciences's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range12
Year Founded2025
Last FundingApr 13, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?